NHS England will be leading a review of low value prescription items from April 2017 and introducing new guidance for Clinical Commissioning Groups (CCGs), with a view to substantially saving NHS expenditure in this area. See more information here
Month: March 2017
Breast Surgery Bulletin- now published
Our Breast Surgery bulletin for March is now published here
Critical Care Bulletin – March
Our latest bulletin for Critical Care is now out – visit the bulletin here
East Cheshire NHS staff can find more information about staying up to date on the library website at http://www.eastcheshirenhslibrary.net/
Sepsis
A great new sepsis bulletin has been published:
https://sepsiscurrentawareness.wordpress.com/
Sign up to receive alerts and stay up-to-date!
Sepsis should be treated within one hour, says NICE
People with life threatening symptoms of sepsis should be reviewed and treated within an hour, the National Institute for Health and Care Excellence (NICE) has recommended. Read the news article here and see the new draft quality standard along with guidance recently published.
All emergency departments must have GP led triage by October
Click for article
Every hospital in England must have a “comprehensive” GP led triage system in emergency departments by October 2017 in a bid to avoid a repeat of the winter crisis that gripped the service this year, NHS leaders have said.
The requirement is one of several “concrete changes” demanded by NHS England’s chief executive, Simon Stevens, and the chief executive of NHS Improvement, Jim Mackey, in a letter sent after the chancellor Philip Hammond’s budget pledge to give the NHS an extra £100m (€115m; $120m) in 2017‑18 to spend on easing pressures in accident and emergency departments.
NICE recommends ixekizumab for persistent severe plaque psoriasis
Click for article
The National Institute for Health and Care Excellence (NICE), in its final draft guidance issued this week, has recommended ixekizumab, an antibody that inhibits interleukin-17A, as an option for treating adults with severe plaque psoriasis that doesn’t respond to standard therapies.
